Literatur
- 1
Coninx R, Maher D, Reyes H, Grzemska M.
Tuberculosis in prison in countries with high prevalence.
BMJ.
2000;
320
440-442
- 2 Crofton J, Chaulet P, Maher D. Guidelines for the management of drug-resistant tuberculosis. Geneva:
WHO/TB96.210 (Rev.1), WHO 1997
- 3
Drobniewski F, Pablos-Méndez A, Raviglione M C.
Epidemiology of tuberculosis in the world.
Sem Resp Crit Care Med.
1997;
18 Nr. 5
419-429
- 4 Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose 2001 .27. Informationsbericht
(2001). pmi Verlagsgruppe Frankfurt/Main (im Druck, erhältlich beim DZK)
- 5
Espinal M. et al .
Global Trends in Resistance to Antituberculosis Drugs.
N Engl J Med..
2001;
344 Nr. 17
1294-1303
- 6 Forßbohm M. Studie des DZK zur Epidemiologie der Tuberkulose - Zwischenbericht 2000. In:
Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose. 27. Informationsbericht (2001).
pmi Verlagsgruppe Frankfurt/Main (im Druck)
- 7
Harries A D, Maher D, Mvula B, Nyangulu D.
An audit of HIV testing and HIV serostatus in tuberculosis patients, Blantyre, Malawi.
Tuberc Lung Dis .
1995;
76 (5)
413-417
- 8
Iseman M D.
Treatment of multidrug-resistant tuberculosis.
N Engl J Med .
1993;
329
784-791
- 9
Loddenkemper R, Hauer B, Sagebiel D, Forßbohm M.
Tuberkuloseepidemiologie in Deutschland und der Welt mit Schwerpunkt Osteuropa.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz.
1999;
42
683-693
- 10
Loddenkemper R.
The need for antituberculosis drug resistance surveillance in Europe.
Eur Respir J.
2000;
16
195-6
- 11 Migliori G B, Raviglione M C. Specific problems in developing areas of the world.
Central and Eastern Europe. In: Davies PDO. „Clinical Tuberculosis” 2nd edition. London:
Chapman & Hall Medical, 1998: 643-660
- 12
Perelman M I.
Tuberculosis in Russia.
Int J Tuberc Lung Dis.
2000;
4 (12)
1097-1103
- 13
Raviglione M C, Rieder H L, Styblo K, Khomenko A G, Esteves K, Kochi A.
Tuberculosis trends in Eastern Europe and the former USSR.
Tuberc Lung Dis.
1994;
75
400-416
- 14
Raviglione M C, Snider D E, Kochi A.
Global Epidemiology of Tuberculosis. Morbidity and Mortality of a Worldwide Epidemic.
JAMA.
1995;
273 Nr. 3
220-226
- 15
Rieder H L, Zellweger J P, Raviglione M C, Keizer S T, Migliori G B.
Tuberculosis control in Europe and international migration.
Eur Respir J.
1994;
7
1545-1553
- 16 Robert Koch-Institut .HIV/AIDS-Bericht II/2000. Epidemiologisches Bulletin (2001)
Sonderausgabe 1/200
- 17 Robert Koch-Institut .HIV-Infektionen/AIDS - globale Situation Ende 1998. Epidemiologisches
Bulletin 20/99
- 18 UNAIDS .AIDS epidemic update 12/2001.
- 19 WHO Report 2001 .Global Tuberculosis Control WHO/CDS/TB2001.287.
- 20 World Health Organization .Treatment of tuberculosis: Guidelines for national programmes. WHO/TB/97.220,
1997
- 21 WHO/IUATLD .Antituberculosis drug resistance in the world. Report No. 2. Prevalence
and trends. WHO/CDS/TB/2000.278 2000
Prof. Dr. R. Loddenkemper
Pneumologische Abteilung II
Lungenklinik Heckeshorn
Zum Heckeshorn 33
14109 Berlin
